(Q35011376)

5 August 2017

1 reference

title

Host genetic determinants of spontaneous hepatitis C clearance (English)

1 reference

5 August 2017

1 reference

Pierre-Yves Bochud

4

0 references

Silvana Gaudieri

series ordinal

2

object named as

Silvana Gaudieri

1 reference

5 August 2017

3

Chloe Thio

1 reference

5 August 2017

Andri Rauch

1

1 reference

ORCID Public Data File 2021

publication date

1 November 2009

1 reference

5 August 2017

1 reference

5 August 2017

10

1 reference

5 August 2017

11

1 reference

5 August 2017

1819-1837

1 reference

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

5 August 2017

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Global challenges in liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Surprisingly small effect of antiviral treatment in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Hepatitis C virus and human immunodeficiency virus coinfection in an urban population: low eligibility for interferon treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Stability of HCV-RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Follow-up studies of treatment for hepatitis C virus infection among injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

T cells and viral persistence: lessons from diverse infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Immunity to hepatitis C virus: stunned but not defeated

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Adaptive immune responses in acute and chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Evasion of intracellular host defence by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Altered innate immunity in chronic hepatitis C infection: cause or effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Flying under the radar: the immunobiology of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Type 1 interferons and the virus-host relationship: a lesson in détente .

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Interferon-inducible antiviral effectors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Interferon regulatory factor-1 promoter polymorphism and the outcome of hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Polymorphisms in TLR2 are associated with increased viral shedding and lesional rate in patients with genital herpes simplex virus Type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Toll-like receptor 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Protective KIR-HLA interactions for HCV infection in intravenous drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

HLA-C and KIR genes in hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Determinants of viral clearance and persistence during acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Immunology of hepatitis B virus and hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

The influence of HLA genotype on AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Host genetic determinants in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

A comparative review of HLA associations with hepatitis B and C viral infections across global populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

HLA-Cw*04 and hepatitis C virus persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

A whole-genome association study of major determinants for host control of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Racial differences in HLA class II associations with hepatitis C virus outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Clearance of hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon-gamma, and outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Polymorphisms in the IL-12B gene and outcome of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Association of interleukin-12 p40 gene 3'-untranslated region polymorphism and outcome of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Regulatory Polymorphisms in the Interleukin‐18 Promoter Are Associated with Hepatitis C Virus Clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Hepatitis C virus-specific cytolytic T lymphocyte and T helper cell responses in seronegative persons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

An analysis of tumor necrosis factor alpha gene polymorphisms and haplotypes with natural clearance of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Association of transforming growth factor-beta 1 functional polymorphisms with natural clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

The reverse stop-signal model for CTLA4 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

High frequency of CCR5-delta32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

HCV chronic infection and CCR5-delta32/delta32.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

The CCR5- 32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Replication of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Low-density lipoprotein receptor variants are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Genetic variations in humans associated with differences in the course of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Does the clinical outcome of hepatitis C infection vary with the infecting hepatitis C virus type?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Hepatitis C virus clearance is prominent in women in an endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Maintenance of MHC polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

CD8 Epitope Escape and Reversion in Acute HCV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Common genetic variation and human traits

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Missingness in the T1DGC MHC fine-mapping SNP data: association with HLA genotype and potential influence on genetic association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Epistatic effects of immunoglobulin GM and KM allotypes on outcome of infection with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Genetic Markers of IgG Influence the Outcome of Infection with Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Viral clearance in hepatitis C (1b) infection: relationship with human leukocyte antigen class II in a homogeneous population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Association between MHC class II alleles and clearance of circulating hepatitis C virus. Members of the Trent Hepatitis C Virus Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

MHC class II genes influence the susceptibility to chronic active hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Increased frequency of the HLA-DR15 (B1*15011) allele in German patients with self-limited hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Association between human leukocytes antigen alleles and chronic hepatitis C virus infection in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Epidemiology and risk factors for hepatitis C in Alaska Natives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

IL-10 and TNF-α polymorphisms and the recovery from HCV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.09.121

21 January 2018

Identifiers

DOI

10.2217/PGS.09.121

1 reference

5 August 2017

1 reference

PubMed ID

19891557